[86] reported that RG7834, a novel oral HBV gene expression inhibitor, could decrease the levels of viral proteins and reduced viremia. RG7834 is a little-molecule compound belonging into the dihydroquinolizinones chemical course similar to RNAi but by means of a unique system.mg drug pre-dissolved in ?L DMSO ( Master liquid concentration mg/mL, Pl